Human in vitro Blood Brain Barrier Model - AIM Biotech

Blood brain barrier (BBB) models are essential for studying the transport efficacy of drugs that target the brain, and for understanding the pathological neurovascular functions in various diseases. Despite the high complexity and high cost of in vivo animal BBB models, 80% of drug candidates that cleared the animal tests failed subsequently in the clinical trials. Therefore, a highly robust, predictive and cost-effective in vitro BBB model is needed. To address this issue, AIM Biotech's microfluidic technology is utilized to create a 3D BBB model through the co-culture of human induced pluripotent stem cell (iPSC)-derived endothelial cells (EC), brain pericytes (PC) and astrocytes (AC). These all-human cells self-organize into a microvascular network within a fibrin gel through vasculogenesis. The BBB model not only exhibits physiologically relevant structures such as tight junction proteins, but more importantly, its permeability is comparable to in vivo values measured in rat brain. This in vitro BBB model can therefore be used to screen for brain-targeting drugs addressing important neurological diseases.